The stock, which is down more than 61% in 2025, sold off after reporting a Q3 EPS beat missing on revenue expectations.
Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...
A new Rough Country Vertex and leaf springs, but this 2023 Toyota Tacoma's driver's side is sitting almost 1.5" lower—super ...
The 1925 Paris Expo established an audacious new design style of architecture, fashion and graphics. In the Watches & ...
Unreal Engine 5.7 is here, bringing you the tools you need to build expansive, lifelike worlds filled with rich, beautiful ...
Odyssey Math Tuition launches a Secondary 2 online math tuition elearning course in Singapore, featuring a proprietary ...
Mayor Wu’s first ever State of the Schools address showcased progress made by the district, while emphasizing there is more work to be done. In a moment when public education is being undermined by ...
Ucupaint 2.4.0 introduces a dedicated alpha channel, decal constraint option and major UI and performance updates for Blender ...
lender 4.5 LTS arrives with studio-grade support; the Blender survey shows where users stand; and Blender 5.0 beta is already here, so its time to plan your upgrade. The Blender Foundation has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback